Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 32 results for "yeda research development company"

The Stockton Group And Yeda Development Company Ltd. Sign An E...

June 2016 Stockton Israel (STK), a leader in innovative botanical based crop protection signed an extension to its joint research agreement with Yeda Research and Development Company Ltd., for the joint research with Prof. Assaf Aharoni's Plant ... BioSpace, 2 weeks ago
Stockton Israel Extends Research Agreement with Yeda Farm Chemicals International, 2 weeks ago
[x]  

120 images for yeda research development company

Nasdaq, 4 days ago
ExecutiveBiz, 8 hours ago
Nasdaq, 6 days ago
Times of India, 2 weeks ago
New Zealand Herald, 2 weeks ago
National Confectioners Association, 2 weeks ago
Irish Examiner, 22 hours ago
Nasdaq, 2 days ago
Food Drink Business Europe, 3 days ago
American Banking News, 2 weeks ago

TxCell announces grant of European patent covering CAR-Tregs for autoimmune & inflammatory diseases

TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, announces the grant by the European Patent Office of the ...
 PharmaBiz1 day ago TxCell Exercises Option from Weizmann Institute of Science Following Effective Grant of Broad CAR-Treg Patent in Europe  Wallstreet Online3 days ago BRIEF-TxCell exercises option from Weizmann institute  Reuters UK3 days ago
[x]  
American Banking News - Forex

FY2016 EPS Estimates for BiondVax Pharma Increased by Analyst (BVXV)

BiondVax Pharma (NASDAQ:BVXV) Zacks Investment Research raised their FY2016 earnings per share (EPS) estimates for shares of BiondVax Pharma in a research report issued to clients and investors on Monday, Zacks Investment Research reports. Zacks ...
 American Banking News - Earnings1 month ago BiondVax Pharma (BVXV) Forecasted to Earn Q1 2016 Earnings of ($0.01) Per Share  Ticker Report1 month ago
International Business Times

XTL BIOPHARMACEUTICALS : Promising Lupus Drug From XTL Biopharmaceuticals Could Be Life Changer In Projected $4 Billion Market

/ Lupus - invisible, silent; an autoimmune disease where the body's defenses mistakenly attack its own cells and living with lupus is never ending. Up to 5 million people, mainly women of childbearing age, suffer progression of this disorder because ...
 4 Traders3 weeks ago Promising Lupus Drug From XTL Biopharmaceuticals Could Be Life Changer In Projected $4 Billion Market  Equities.com3 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
 
More     Less